Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1G93A mice model of ALS

被引：0
|
作者：
Inna Rabinovich-Nikitin
Assaf Ezra
Beka Barbiro
Polina Rabinovich-Toidman
Beka Solomon
机构：
[1] Tel Aviv University,Department of Molecular Microbiology and Biotechnology, George S. Wise Faculty of Life Sciences
来源：
Journal of Neuroinflammation | / 13卷
关键词：
Microglia; Blood-spinal cord barrier; AMD3100; ALS; SOD1; mice; Hematopoietic stem and progenitor cells; CXCR4/CXCL12;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The Pathogenesis of Chlorovirus Infection in SOD1G93A Transgenic Mice and Clinical Implications for ALS
    Pattee, Gary
    Petro, Tom
    Dunigan, David
    Agarkova, Irina
    Van Etten, James
    NEUROLOGY, 2020, 94 (15)
  • [22] DANTROLENE IS NEUROPROTECTIVE IN VITRO, BUT DOES NOT AFFECT SURVIVAL IN SOD1G93A MICE
    Staats, K. A.
    Van Rillaer, M.
    Scheveneels, W.
    Verbesselt, R.
    Van Damme, P.
    Robberecht, W.
    Van den Bosch, L.
    NEUROSCIENCE, 2012, 220 : 26 - 31
  • [23] STATINS ACCELERATE DISEASE PROGRESSION AND SHORTEN SURVIVAL IN SOD1G93A MICE
    Su, Xiaowei W.
    Nandar, Wint
    Neely, Elizabeth B.
    Simmons, Zachary
    Connor, James R.
    MUSCLE & NERVE, 2016, 54 (02) : 284 - 291
  • [24] Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1G93A Model
    Ariel Ionescu
    Tal Gradus
    Topaz Altman
    Roy Maimon
    Noi Saraf Avraham
    Michal Geva
    Michael Hayden
    Eran Perlson
    Cell Death & Disease, 10
  • [25] Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1G93A Model
    Ionescu, Ariel
    Gradus, Tal
    Altman, Topaz
    Maimon, Roy
    Avraham, Noi Saraf
    Geva, Michal
    Hayden, Michael
    Perlson, Eran
    CELL DEATH & DISEASE, 2019, 10 (3)
  • [26] Sigma-1 Receptor is a Pharmacological Target to Promote Neuroprotection in the SOD1G93A ALS Mice
    Gaja-Capdevila, Nuria
    Hernandez, Neus
    Navarro, Xavier
    Herrando-Grabulosa, Mireia
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [27] Genetic ablation of IP3 receptor 2 increases cytokines and decreases survival of SOD1G93A mice
    Staats, Kim A.
    Humblet-Baron, Stephanie
    Bento-Abreu, Andre
    Scheveneels, Wendy
    Nikolaou, Alexandros
    Deckers, Kato
    Lemmens, Robin
    Goris, An
    Van Ginderachter, Jo A.
    Van Damme, Philip
    Hisatsune, Chihiro
    Mikoshiba, Katsuhiko
    Liston, Adrian
    Robberecht, Wim
    Van Den Bosch, Ludo
    HUMAN MOLECULAR GENETICS, 2016, 25 (16) : 3491 - 3499
  • [28] Cdk5 inhibition in the SOD1G93A transgenic mouse model of ALS suppresses neurodegeneration and extends survival
    Kim, A.
    Lee, D.
    Sung, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 445 - 446
  • [29] The Wlds gene modestly prolongs survival in the SOD1G93A
    Fischer, LR
    Culver, DG
    Davis, AA
    Tennant, P
    Wang, MS
    Coleman, M
    Asress, S
    Adalbert, R
    Alexander, GM
    Glass, JD
    NEUROBIOLOGY OF DISEASE, 2005, 19 (1-2) : 293 - 300
  • [30] Preservation of masseter muscle until the end stage in the SOD1G93A mouse model for ALS
    Kawata, Sou
    Seki, Soju
    Nishiura, Akira
    Kitaoka, Yoshihiro
    Iwamori, Kanako
    Fukada, So-ichiro
    Kogo, Mikihiko
    Tanaka, Susumu
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345